—

argenx NV ADR (ARGX) — the peer cohort

As of 2026-11-09 — scores re-bake nightly. Cohort = shared Closelooknet index membership first, then sector. Diary readings, not advice.

argenx NV ADR ranks 5 of 7 in its cohort on the Closelooknet composite (64/100) — the cohort is led by Halozyme Therapeutics Inc at 71/100.

NameCompositeMomentumQualityValuationSignalOff 52w high
ARGX argenx NV ADR 64 78 74 28 ok 10.3%
HALO Halozyme Therapeutics Inc 71 75 94 38 info 23.2%
ARGX.BR Argen-X 65 82 75 29 ok 7.7%
ONC BeOne Medicines AG 65 91 64 30 ok 0.6%
REGN Regeneron Pharmaceuticals Inc 65 83 73 46 watch 8.8%
BION.SW BB Biotech AG 60 73 95 73 ok 6.1%
RIGL Rigel Pharmaceuticals Inc 60 76 89 74 info 20.1%

Scores are relative readings across the Closelooknet coverage universe — methodology in the company-scoring explainer. Signal lights come from the nightly signal board.

FAQ · from the current data · as of 2026-11-09

Quick answers

Who are argenx NV ADR's peers in the Closelooknet universe?

The cohort is drawn from shared Closelooknet index membership first, then sector: Halozyme Therapeutics Inc (HALO), Argen-X (ARGX.BR), BeOne Medicines AG (ONC), Regeneron Pharmaceuticals Inc (REGN), BB Biotech AG (BION.SW), Rigel Pharmaceuticals Inc (RIGL), as of 2026-11-09.

How does ARGX score against its peers?

argenx NV ADR's composite reads 64/100, ranking 5 of 7 in its cohort as of 2026-11-09; the cohort's highest composite is Halozyme Therapeutics Inc at 71/100. Closelooknet scores are research diary readings, not ratings or advice.

Mentioned on Closelooknet

Where ARGX appears in the diary — 1 piece, newest first. Every link is our own writing.

Dailies

Related in the Closelooknet universe

then Biotechnology. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.